<unk>  (varicella zoster virus) globulin or<unk>  antibodies is an immune system medication that is used mostly for immunosuppressed patients who have been or may be exposed to the varicella zoster virus. It shortens the course of cutaneous disease and may protect against its dissemination. Varicella zoster virus is a human herpes virus that causes chickenpox, shingles, Ramsay Hunt syndrome type II, and postherpetic neuralgia. Unlike a Zoster vaccine which provides durable immunity, the protection is passive and short term; it may need to be readministered every 2-4 weeks as necessary. This medication is not recommended for administration to immune-competent persons for treatment of active disease. The immunoglobulin is prepared from the plasma of healthy donors with high titers of antibodies to<unk> . A study was published in the Journal of Infectious Diseases that showed outdated blood from blood banks may have antibody concentrations that were equivalent to those in plasma of donors recovering from recent<unk>  infection that resulted in elevated levels of zoster immune globulin. Another study published in the Journal of Infectious Diseases proved that varicella zoster immune globulin (VZIG) can be administered to children with suppressed immune systems to protect them against severe chicken pox. A study also published in the Journal of Infectious Diseases found that immunocompetent subjects exposed to<unk>  resulting in an increased level of<unk>  antibodies suggests that subclinical reinfection occurs.
VZV immune globulin
Vaccinia immune globulin
Hepatitis B immune globulin
MRNA vaccine
Edible algae vaccine
Pipeline vaccine
Genetic vaccine
DPT vaccine